Brokerages Set Masimo Corporation (NASDAQ:MASI) Price Target at $180.40

Masimo Corporation (NASDAQ:MASI) has been assigned a consensus rating of “Hold” from the nine analysts that are currently covering the company, MarketBeat.com reports. Nine investment analysts have rated the stock with a hold rating. The average 12-month price target among brokerages that have issued ratings on the stock in the last year is $180.40.

A number of equities analysts have recently commented on MASI shares. Wolfe Research downgraded shares of Masimo from a “strong-buy” rating to a “hold” rating in a research note on Thursday, February 19th. Piper Sandler downgraded shares of Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target on the stock. in a research note on Tuesday, February 17th. BTIG Research downgraded shares of Masimo from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 18th. Weiss Ratings raised shares of Masimo from a “sell (d-)” rating to a “hold (c-)” rating in a research note on Wednesday, May 6th. Finally, Wells Fargo & Company raised shares of Masimo to a “hold” rating in a research note on Wednesday, March 18th.

Institutional Investors Weigh In On Masimo

Several hedge funds and other institutional investors have recently added to or reduced their stakes in MASI. Global Retirement Partners LLC purchased a new stake in Masimo during the 4th quarter worth $27,000. Aster Capital Management DIFC Ltd purchased a new stake in Masimo during the 4th quarter worth $28,000. Los Angeles Capital Management LLC purchased a new stake in Masimo during the 4th quarter worth $31,000. Rothschild Investment LLC increased its stake in Masimo by 12,950.0% during the 4th quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock worth $34,000 after buying an additional 259 shares during the period. Finally, Torren Management LLC purchased a new stake in Masimo during the 4th quarter worth $35,000. Hedge funds and other institutional investors own 85.96% of the company’s stock.

Masimo Stock Performance

Shares of MASI stock opened at $179.95 on Wednesday. The company’s fifty day simple moving average is $178.70 and its 200-day simple moving average is $160.55. Masimo has a 52 week low of $125.94 and a 52 week high of $179.99. The company has a current ratio of 2.68, a quick ratio of 1.45 and a debt-to-equity ratio of 0.56. The company has a market cap of $9.42 billion, a PE ratio of -17.07, a P/E/G ratio of 1.82 and a beta of 1.11.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.